BCEIE › News › THEMISMED

Results

Themis Medicare: Kindly refer to the Un-audited standalone and consolidated financial results for the quarter and half year…

Themis Medicare (THEMISMED) filed a disclosure titled "Kindly refer to the Un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026". The company is valued at about ₹940 crore.

BCEIE News Desk · Published 14 Nov 2026, 05:25 pm IST · Filing received 14 Nov 2026, 05:09 pm IST

What happened

Themis Medicare (THEMISMED) filed a disclosure with the exchanges on 14 November 2026 at 05:09 PM titled "Kindly refer to the Un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026".

Company snapshot

Themis Medicare is a micro-cap company, with a market value of about ₹940 crore.

The stock last traded at ₹102.1, against a 52-week range of ₹64.95–₹140.6 (27.4% below the high).

Before this filing the shares had moved −4.4% over the month and −1.8% over three months. Average daily turnover over the last 20 sessions was about ₹0.52 crore.

Promoters held 67.11% at the end of Q1 FY27; 43.39% of promoter shares were pledged. Foreign institutions owned 0.01% and domestic institutions 0.01%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2698-14.2-1.54
Q2 FY2678-3.6-0.39
Q3 FY269010.11.1
Q4 FY26778.90.96
Q1 FY278724.62.67

What history shows

BCEIE's records show 3 previous results filings from the company since May 2026.

After those filings, the stock fell 5.7% on average the next trading day and was down 7.4% on average after five days (2 filings with price data).

Market-wide, 11,788 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.

Past reactions describe what happened before; they are not a forecast.

Earlier filings of this kind
DateFilingNext day5 days
28 May 2026Results_Audited Standalone And Consolidated Financial Results For…−7.5%−8.4%
28 May 2026, the financial results for the period ended March 31, 2026.−3.8%−6.4%

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.
  • 14 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Themis Medicare Limited